RDY 613 (Pramipexole Dihydrochloride Extended-Release 1.5 mg)
Pill with imprint RDY 613 is White, Elliptical/Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 1.5 mg. It is supplied by Dr. Reddy's Laboratories Limited.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RDY 613
Pramipexole Dihydrochloride Extended-Release
- Imprint
- RDY 613
- Strength
- 1.5 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories Limited
- National Drug Code (NDC)
- 55111-0613
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
carbomer homopolymer type A,
corn starch
Note: Inactive ingredients may vary.
More about pramipexole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (216)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.